Dr. Brian J. Czerniecki, MD

Dr. Czerniecki practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Czerniecki's NPI, 1881620938, was assigned on June 23, 2006. Dr. Czerniecki graduated from Rutgers Robert Wood Johnson Medical School in 1988. Dr. Czerniecki's Pennsylvania license number on file is MD056377L.

Dr. Czerniecki's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Czerniecki also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Dr. Czerniecki's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Czerniecki to 1 more breast imaging center, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Czerniecki practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Czerniecki's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Czerniecki is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Czerniecki's licenses on file in 3 states: Pennsylvania, Florida and Ohio.

Dmand AI lists breast reconstruction, breast surgery and mastectomy among the conditions Dr. Czerniecki treats.

CMS data shows 145 Medicare services from Dr. Czerniecki across 6 procedure codes in 2024, for 67 Medicare patients. Medicare paid $50,867 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 67 Medicare patients who saw Dr. Czerniecki in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Czerniecki's median patient age at 62, with 98% women.

In 2024, Dr. Czerniecki wrote 13 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $87 in total drug cost. In 2018, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Czerniecki for performance year 2024, reported as part of a group. Dr. Czerniecki accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 54 procedures of mastectomy by Dr. Czerniecki, more than 95% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 198 papers to Dr. Czerniecki, published from 2003 to 2025. 2021 was the busiest year, with 14. The most frequent topics are Breast Neoplasms, Dendritic Cells and Receptor, ErbB-2. Dr. Czerniecki has published most often in Ann Surg Oncol. Dr. Czerniecki's most frequent co-authors are Hatem H. Soliman, MD, Ricardo Lima Barros Costa, MD and Hyo Sook Han, MD.

Dmand AI links Dr. Czerniecki to 6 clinical trials, 4 of them phase 1 studies. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Intraductal, Noninfiltrating. H. Lee Moffitt Cancer Center and Research Institute sponsors the most, 3.

CMS Open Payments shows 44 general payments to Dr. Czerniecki from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. Merit Medical Systems Inc paid the most, $20,585.

Dmand AI lists 6 awards for Dr. Czerniecki, most recently America's Top Doctors in 2014.

Dr. Czerniecki graduated from Rutgers Robert Wood Johnson Medical School in 1988. Dr. Czerniecki is a member of ACS.

Dr. Czerniecki is in network with 15 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.